JOTEC
JOTEC is a German privately held medical device company, founded in 2000 in Hechingen, that develops, produces, and markets implantable aortic and peripheral vascular devices — primarily stent graft systems — for cardiac and vascular surgeons and hospital systems.
- Company typePrivate
- Founded2000
- HeadquartersHechingen, Germany
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What JOTEC does
JOTEC is a privately held German medical device company headquartered in Hechingen, founded in 2000, operating with 251–500 employees. According to its firmographic profile, JOTEC develops, produces, and markets medical devices for the treatment of aortic and peripheral vascular disease. Its portfolio of branded devices historically centers on endovascular stent graft systems and complementary delivery/accessory tools, including the E-TEGRA abdominal aortic stent graft system, the E-LIAC stent graft system for peripheral/abdominal use, the E-vita Open NEO hybrid stent graft for the aortic arch, the E-xtra Design MultiBranch and E-NSIDE TAAA multibranch systems for thoracoabdominal repair, the E-XPAND stent graft balloon catheter, and the E-WIRE guidewire. These product lines now appear within the Artivion (formerly CryoLife) aortic platform's public product catalog, indicating that JOTEC's commercial assets have been folded into a larger corporate parent, although the transaction itself is not explicitly described in the provided source data.
JOTEC's revenue mechanics are not disclosed in the source material. As a manufacturer of Class III implantable vascular devices, the typical business model involves direct sales and distributor relationships with hospitals and specialist cardiac/vascular surgeons, premium implant-level pricing, and a regulatory-clearance-driven go-to-market cadence. The company does not expose any public API, SDK, or digital platform (api_exists: false), and no proprietary software, AI/ML capabilities, or data flywheel is documented. Customer concentration, pricing, partnerships, and sales-channel mix are likewise not provided, leaving meaningful gaps in the investment picture.
The most strategically relevant observable signal is that JOTEC's device family is now embedded within a broader aortic franchise alongside adjacent arch and thoracoabdominal products (NEXUS family, AMDS Hybrid Prosthesis, CryoValve, BioGlue) and within a clinical pipeline that includes the AMDS PERSEVERE trial (enrollment completed November 2023, FDA Humanitarian Device Exemption granted December 2024, late-breaking one-year data presented January 2025). This positions JOTEC's assets within an ongoing aortic consolidation strategy, but JOTEC-specific financials, headcount trend, and standalone strategic moves are not present in the supplied data.
JOTEC firmographics
Firmographics- Name
- JOTEC
- Website
- https://jotec.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- JOTEC is a German privately held medical device company, founded in 2000 in Hechingen, that develops, produces, and markets implantable aortic and peripheral vascular devices — primarily stent graft systems — for cardiac and vascular surgeons and hospital systems.
- Ownership category
- akta.pro rank
JOTEC industry classification
Industry- Product category
- Vascular Medical Devices
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts (HLAHAFAF)
- akta.pro secondary industries
- Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE), Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)
Keywords
Where JOTEC is headquartered
LocationHeadquarters
- HQ city
- Hechingen
- HQ country
- Germany
- HQ region
- Europe
Markets served
JOTEC business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
JOTEC product offering
Product offeringCore offering
JOTEC develops, produces, and markets medical devices for aortic and peripheral vascular disease. The company's portfolio centers on endovascular stent graft systems and hybrid prostheses used in the treatment of aortic and peripheral vascular conditions, including devices for abdominal aortic repair, iliac and peripheral vascular applications, thoracoabdominal repair, and aortic arch procedures.
Product overview
No product information for JOTEC is present in the provided source data. The sources contain medical device market analysis (PTA Balloon Catheters) and Artivion company information (aortic medical devices including heart valves, allografts, stent grafts, and surgical sealants), but no references to JOTEC products, services, or company details.
Differentiator
Problem solved
Functional benefit
Products and services
- Aortic and Peripheral Vascular Medical Devices
Companies that use JOTEC
Customer profileIdeal customer profiles1 record
JOTEC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
JOTEC partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
JOTEC competitors and assessment
Company assessmentBroad incumbents
- Getinge (Maquet): Medical-device conglomerate with vascular surgery grafts (including open and hybrid aortic solutions). Competes in adjacent aortic and peripheral segments with broader hospital capital equipment exposure than JOTEC.
- Abbott Vascular: Abbott's cardiovascular division offers peripheral intervention and structural heart products. Competes with JOTEC in peripheral vascular intervention and shares the same hospital customer base for endovascular procedures.
- Medtronic: Global medical device leader with the Endurant abdominal and Valiant thoracic stent graft systems. Direct competitor in EVAR/TEVAR with substantially larger R&D, clinical-evidence, and commercial reach versus JOTEC.
- Becton, Dickinson and Company (BD): Diversified medical-technology manufacturer with peripheral vascular, surgical, and endovascular product lines. Overlaps with JOTEC in peripheral vascular intervention and catheters.
- Artivion: Parent company of JOTEC and a focused aortic franchise including heart valves, allografts, and stent grafts (e.g., AMDS, On-X, NEXUS). While a parent rather than a peer in the strict sense, the aortic portfolio overlaps substantially with JOTEC's offerings and provides the closest reference benchmark.
Emerging players
- Penumbra: Developer of catheter-based thrombectomy and peripheral vascular intervention devices. Competes with JOTEC in peripheral vascular and catheter-delivered therapies, though with a different procedural focus.
- LeMaitre Vascular: Specialty vascular surgery device company with a portfolio of biologic patches, carotid shunts, and catheters. Smaller and more focused than JOTEC, but competes in adjacent peripheral and vascular surgery niches.
Direct peers
- Terumo Aortic: Aortic and peripheral division of Terumo, formed from the Vascutek and Bolton Medical combinations. Competes head-to-head with JOTEC in open surgical grafts and thoracic/abdominal stent grafts.
- Cook Medical: Developer of the Zenith family of aortic stent grafts and a broad peripheral vascular intervention portfolio. Direct competitor across abdominal, thoracic, and peripheral vascular segments where JOTEC operates.
- W. L. Gore & Associates (Gore Medical): Privately held manufacturer of the Excluder (AAA) and TAG/Conformable GORE TAG (TAA) endovascular stent graft families. Closest direct competitor to JOTEC's E-tegra and thoracic platforms, with deep surgeon relationships and a long clinical track record.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
JOTEC social profiles
Digital presenceJOTEC financial estimates
Financial estimateRevenue estimate
Valuation estimate
JOTEC leadership team
Management profileNumber of profiles
JOTEC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JOTEC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JOTEC
What does JOTEC do?
JOTEC develops, produces, and markets medical devices for aortic and peripheral vascular disease. The company's portfolio centers on endovascular stent graft systems and hybrid prostheses used in the treatment of aortic and peripheral vascular conditions, including devices for abdominal aortic repair, iliac and peripheral vascular applications, thoracoabdominal repair, and aortic arch procedures.
Is JOTEC a public or private company?
JOTEC is a private company. It is classified as unknown and is currently operating.
When was JOTEC founded?
JOTEC was founded in 2000. It employs 251 to 500 people.
Where is JOTEC based?
JOTEC is headquartered in Hechingen, Germany, in the Europe region.
Who are JOTEC's main competitors?
Broad incumbents on record are Getinge (Maquet), Abbott Vascular, Medtronic, Becton, Dickinson and Company (BD) and Artivion. Emerging players are Penumbra and LeMaitre Vascular. Direct peers are Terumo Aortic, Cook Medical and W. L. Gore & Associates (Gore Medical).
Does JOTEC have an API?
No public API is recorded for JOTEC.
What industry is JOTEC in?
JOTEC's product category is Vascular Medical Devices. Its primary akta.pro industry code is HLAHAFAF, Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts, with a secondary code of HLAHAFAE, Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy). Its SIC code is 3841.